Cytokines in sleep regulation
References (181)
Blocking NMDA receptors or nitric oxide production disrupts light transmission to the suprachiasmatic nucleus
Brain Res.
(1992)- et al.
Muramyl peptides as immunopharmacological response modifiers
- et al.
Cytokines in neuronal cell types
Neurochem. Int.
(1993) - et al.
Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglia cells
J. Neuroimmunol.
(1992) - et al.
Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures
Brain Res.
(1993) - et al.
Signals involved in interleukin-1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages
Cytokine
(1990) Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats
Brain Res.
(1986)- et al.
Enhancement of slow-wave sleep parallel to the satiating effect of acidic fibroblast growth factor in rats
Brain Res. Bull.
(1992) - et al.
Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone
Neuropharmacology
(1990) Interleukin-1 and interleukin-1 antagonism
Blood
(1991)
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
J. Neuroimmunol.
Induction of interleukin-1β mRNA in adult rat brain
Molec. Brain Res.
Tumor necrosis factor-alpha gene expression in the tissues of normal mice
Cytokine
Ultrastructural localization of fibroblast growth factor in neuron of rat brain
Neurosci. Lett.
Humoral regulation of sleep
Int. Rev. Neurobiol.
Inhibition of nitric oxide synthesis inhibits rat sleep
Brain Res.
Identification and characterization of receptors for tumor necrosis factor-alpha in the brain
Biochem. Biophys. Res. Commun.
Somnogenic activity of immune response modifiers
TIPS
Sleep as a host defense: its regulation by microbial products and cytokines
Clin. Immunol. Immunopathol.
The composition of sleep-promoting factor isolated from human urine
J. Biol. Chem.
Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination
J. Biol. Chem.
Bacterial peptidoglycan as modulators in sleep. II. Effects of muramyl peptides on the structure of rabbit sleep
Brain Res.
Interferon alpha-2 enhances slow-wave sleep in rabbits
Int. J. Immunopharmac.
Immunoreactive interleukin-1β localization in the rat forebrain
Brain Res.
Nucleotide sequence of bovine clone encoding the angiogenic protein, basic fibroblast growth factor
Science
Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase
Phosphatidylcholine hydrolysis activates NF-κB and increases human immunodeficiency virus replication in human monocytes and T lymphocytes
J. Virol.
Brain nitric oxide synthase activity and sleep
Sleep Res.
Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism
J. Pharmac. Expl Ther.
Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action
Cell Physiol.
Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation
Circ. Res.
Interleukin-1 immunoreactive innervation of the human hypothalamus
Science
Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system
J. Comp. Neurol.
Regional induction of tumor necrosis factor α expression in the mouse brain after systemic lipopolysaccharide administration
Somnogenic activities of synthetic lipid A
Infect. Immun.
Viral infection and host defense
Science
Immunopharmacology of muramyl peptides: new horizons
Prog. Immunol.
Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1
J. Immunol.
Interleukin 1 receptors in the brain and endocrine tissues
Immunol. Today
Localization of interleukin-1 receptor messenger RNA in murine hippocampus
Endocrinology
Interferon modified EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats
Neurotoxicology
Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivate
Int. J. Immunol. Pharmac.
Evidence for separate receptors for insulin-like growth factor-I in choroid plexus of rat brain by quantitative autoradiography
J. Histochem. Cytochem.
Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages
J. Immunol.
Interferons and other Regulatory Cytokines
Interleukin-1
Rev. Infect. Dis.
Induction of interleukin-1 by synthetic and naturally occurring muramyl peptides
Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO
Science
Cloning and expression of two distinct high-affinity receptors crossreacting with acidic and basic fibroblast growth factors
EMBO J.
Cytokines as mediators of chronic inflammatory disease
Cited by (89)
Sleep fragmentation disrupts Lyme arthritis resolution in mice
2024, Sleep MedicineEffects of an interleukin-1 receptor antagonist on human sleep, sleep-associated memory consolidation, and blood monocytes
2015, Brain, Behavior, and ImmunityCitation Excerpt :Sleep and the immune system are thought to interact such that sleep promotes immune defense and immune responses to infectious agents convey an enhancing influence on sleep (Besedovsky et al., 2012; Imeri and Opp, 2009). Stimulated by early work that identified a muramyl peptide, i.e., a fragment of bacterial cell walls, as potent sleep promoting factor (Krueger et al., 1982), the idea has been around for a long time that pro-inflammatory cytokines that are released in response to microbial challenge are involved in the homeostatic regulation of sleep, especially of slow wave sleep (SWS) (Krueger and Majde, 1994; Krueger et al., 1995). Interleukin-1 beta (IL-1) and tumor necrosis factor (TNF), two important cytokines mediating inflammatory processes, are considered major players in this context (Krueger et al., 2007).
Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse
2015, Brain, Behavior, and ImmunityCitation Excerpt :It is unclear the cellular benefit or detriment of this acute post-traumatic sleep on recovery following TBI, however, we have previously shown immediate disruption of post-traumatic sleep does not worsen injury-induced motor or cognitive deficits (Rowe et al., 2014a) in the mouse. While the role of post-traumatic sleep in the pathophysiology of TBI remains unclear, data support a mechanistic link between inflammation and the induction of sleep (Krueger et al., 1995, 2007, 2001; Rowe et al., 2014). SPMs including RvE1 and AT-RvD1 may resolve inflammation resulting from TBI, as incorporated into the extended drug delivery design, and subsequently attenuate post-traumatic sleep disorders.
Prevalence and predictors of obstructive sleep apnea in patients admitted for acute myocardial infarction
2014, Annales de Cardiologie et d'AngeiologieInflammation at the intersection of behavior and somatic symptoms
2011, Psychiatric Clinics of North AmericaSleep patterns in patients with acute coronary syndromes
2010, Sleep MedicineCitation Excerpt :The acute phase of the illness and its consequences in circulating cytokines and other inflammatory mediators may play a major role in sleep disruption and deserve further research. The expression of many cytokines is upregulated in patients with ACS [35], with inflammatory cytokines having both somnogenic and sleep-inhibitory effects depending on the type, dose and circadian time of application, and it has been reported to influence sleep and sleep depth [36]. One possible limitation of our study is the absence of a control group.